Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 1 |
2021 | 3 |
2022 | 3 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
Expert Rev Proteomics. 2020 Jan;17(1):1-10. doi: 10.1080/14789450.2020.1717951. Epub 2020 Jan 23.
Expert Rev Proteomics. 2020.
PMID: 31945303
Review.
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.
van Dijk AD, Griffen TL, Qiu YH, Hoff FW, Toro E, Ruiz K, Ruvolo PP, Lillard JW Jr, de Bont ESJM, Burger JA, Wierda W, Kornblau SM.
van Dijk AD, et al.
Leukemia. 2022 Mar;36(3):712-722. doi: 10.1038/s41375-021-01438-4. Epub 2021 Oct 8.
Leukemia. 2022.
PMID: 34625713
Item in Clipboard
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Hoff FW, Van Dijk AD, Qiu Y, Hu CW, Ries RE, Ligeralde A, Jenkins GN, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Qutub AA, De Bont ESJM, Horton TM, Kornblau SM.
Hoff FW, et al. Among authors: van dijk ad.
Haematologica. 2022 Oct 1;107(10):2329-2343. doi: 10.3324/haematol.2021.279672.
Haematologica. 2022.
PMID: 35021602
Free PMC article.
Item in Clipboard
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA.
van Dijk AD, Hoff FW, Qiu Y, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, Jenkins GN, de Bont ESJM, Kornblau SM, Horton TM.
van Dijk AD, et al.
Proteomics Clin Appl. 2022 Mar;16(2):e2100072. doi: 10.1002/prca.202100072. Epub 2021 Nov 17.
Proteomics Clin Appl. 2022.
PMID: 34719869
Free PMC article.
Clinical Trial.
Item in Clipboard
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.
Hoff FW, van Dijk AD, Qiu Y, Ruvolo PP, Gerbing RB, Leonti AR, Jenkins GN, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Bruggeman SWM, Kornblau SM, Horton TM.
Hoff FW, et al. Among authors: van dijk ad.
Blood. 2021 Feb 25;137(8):1050-1060. doi: 10.1182/blood.2020005208.
Blood. 2021.
PMID: 32959058
Free PMC article.
Clinical Trial.
Item in Clipboard
Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients.
van Dijk AD, Hu CW, de Bont ESJM, Qiu Y, Hoff FW, Yoo SY, Coombes KR, Qutub AA, Kornblau SM.
van Dijk AD, et al.
Proteomics. 2018 Apr;18(8):e1700379. doi: 10.1002/pmic.201700379. Epub 2018 Apr 2.
Proteomics. 2018.
PMID: 29505696
Item in Clipboard
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
van Dijk AD, Hoff FW, Qiu Y, Hubner SE, Go RL, Ruvolo VR, Leonti AR, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Horton TM, Kornblau SM.
van Dijk AD, et al.
Cancers (Basel). 2024 Apr 9;16(8):1448. doi: 10.3390/cancers16081448.
Cancers (Basel). 2024.
PMID: 38672531
Free PMC article.
Item in Clipboard
Cite
Cite